Process Engineer, MSAT, Drug Substance

Amylyx Pharmaceuticals•Cambridge, MA
•$171,000 - $192,000•Remote

About The Position

Amylyx is seeking a Principal Process Engineer, MSAT Drug Substance, to serve as the global process owner and technical subject matter expert for avexitide, a GLP-1 antagonist peptide drug substance. The role partners with Quality, QC, CMC, and External Manufacturing teams to support reliable, compliant, and efficient manufacturing. It is accountable for drug substance technology transfer, process validation, continued process verification, investigations, change control, and process lifecycle management, while building collaborative relationships with internal and external stakeholders. The position reports to the Director, Manufacturing Sciences and Technology. The role provides technical leadership across clinical and commercial drug substance manufacturing at external CDMOs. Key activities include representing MSAT on CMC teams, supporting regulatory submissions and agency responses, managing process transfers and validation, leading manufacturing investigations and CAPAs, and monitoring process performance through continued process verification and data trending. The engineer also identifies and implements continuous improvement opportunities to improve process robustness, impurity control, yield, cycle time, capacity, and operational efficiency. The position supports remote work within the United States, but requires regular ability to attend meetings at the Cambridge, Massachusetts office. Preference is given to candidates in New England who can attend in person as needed. Remote workers must have a suitable work setting, including privacy, reliable internet, phone, and video-conferencing capability. Travel to domestic and international CMOs may be required up to 20%. The estimated base salary range is $171,000–$192,000 USD. Eligible employees may also receive annual performance-based bonuses and equity awards, and Amylyx offers a comprehensive benefits package.

Requirements

  • Bachelor’s degree in chemical engineering or a related field with at least 10 years of relevant experience, or a master’s degree with at least 8 years of relevant experience.
  • Experience with late-phase or commercial peptide or biologic drug substance manufacturing is required.
  • Experience with relevant downstream operations, including chromatography purification, ultrafiltration or diafiltration, and lyophilization.
  • Comprehensive understanding of cGMP principles and regulatory requirements, including process, equipment, and facility validation.
  • Detail-oriented, with strong problem-solving skills and the ability to identify subtle trends in data.
  • Excellent communication and teamwork skills.
  • Ability to lead technical discussions with external partners, influence cross-functional decisions without direct authority, and communicate complex process risks to technical and non-technical stakeholders.
  • Ability to travel to domestic and international CMOs up to 20%.
  • For remote work, access to a work setting that supports privacy, reliable internet, phone access, and video conferencing.
  • Ability to attend meetings at the Cambridge, Massachusetts office on a regular basis.

Nice To Haves

  • Experience with liquid phase, hybrid, tag-assisted synthesis, or green chemistry peptide manufacturing.
  • Familiarity with modeling and optimization tools such as MATLAB or JMP.
  • Residence in the New England region and ability to attend in person as needed.

Responsibilities

  • Serve as global process owner for assigned products, ensuring comparability across manufacturing locations.
  • Author and review regulatory submissions, validation reports, and responses to regulatory agency questions.
  • Represent MSAT on CMC teams as the product drug substance owner and process subject matter expert.
  • Assess technical and regulatory impacts of potential global process changes.
  • Author annual product reviews and assessments to satisfy global health authority requirements.
  • Lead process transfers to new manufacturing sites or larger-scale facilities.
  • Partner with technical development to evaluate and implement new process technology as needed.
  • Lead drug substance technology transfer between clinical, validation, and commercial manufacturing sites.
  • Define critical process parameters, critical quality attributes, and in-process controls for peptide drug substance unit operations.
  • Develop and execute process validation strategies, including PPQ planning, statistical sampling plans, and acceptance criteria aligned with regulatory guidance.
  • Support drug substance introductions and commercial launches by ensuring peptide manufacturing processes are validated, scalable, robust, and inspection-ready.
  • Provide technical leadership and day-to-day process engineering support for clinical and commercial drug substance manufacturing at external CDMOs.
  • Serve as the process engineering subject matter expert during manufacturing operations and provide onsite support when required.
  • Lead investigations, conduct root cause analysis, and develop scientifically sound CAPAs aligned with regulatory expectations and industry best practices.
  • Assess and author technical risk assessments and change controls for manufacturing changes, investigations, and regulatory filings.
  • Ensure compliance with cGMPs, global regulatory requirements, and internal quality systems for drug substance manufacturing.
  • Review and provide technical input on master batch records, campaign readiness plans, process descriptions, and manufacturing documentation.
  • Lead continued process verification and routine data trending for manufacturing unit operations, in-process controls, and critical process parameters.
  • Develop and maintain data repositories, dashboards, and KPIs to assess process capability, performance, and trends.
  • Identify process drift, yield loss, impurity shifts, raw material variability, and scale-dependent performance risks, and drive corrective or preventive actions.
  • Prepare and present quarterly CPV summaries and technical assessments for internal management reviews.
  • Identify and execute continuous improvement initiatives focused on process robustness, impurity control, yield, cycle time, capacity, and operational efficiency.
  • Apply Quality by Design, Design of Experiments, statistical process control, and risk-based decision-making to optimize drug substance manufacturing processes.
  • Collaborate with CDMOs to implement best practices, new technologies, and process enhancements where appropriate.
  • Travel to domestic and international CMOs up to 20%.

Benefits

  • Eligible employees may receive annual performance-based bonuses.
  • Eligible employees may receive equity awards.
  • Comprehensive benefits package designed to support employee health, well-being, and financial security.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service